Innova Captab, a company in the Pharmaceuticals industry, reported revenue of ₹471 crore and net profit of ₹44 crore for the June 2026 quarter.
Innova Captab (NSE: INNOVACAP) closed at ₹977.80 on 20 Nov 2026, up 33.5% over the past year. Its market capitalisation is ₹5,595 crore and it trades at 33.5 times earnings.
Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.